Huber, R M <br/><br/>
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer.  [electronic resource] 

 -  The European respiratory journal  Jun 2006 
 - 1183-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0903-1936 
<br/><br/><label>Standard No.: </label>10.1183/09031936.06.00015605  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Small Cell--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Leukocyte Count<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Neutropenia--chemically induced<br/>Neutrophils--drug effects<br/>Organoplatinum Compounds--therapeutic use<br/>Platelet Count<br/>Retreatment<br/>Survival Rate<br/>Topotecan--administration & dosage<br/>Treatment Outcome